BAYER AKTIENGESELLSCHAFT «...678910...» Página 10 de 137 desde 01/07/1988 hasta 12/07/2024 24/08/2018 09:58 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease Número de registro: 269140 22/08/2018 10:10 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Q2 2018 Publication Schedule Número de registro: 269109 22/08/2018 08:30 BAYER AKTIENGESELLSCHAFT Others on business performance and financial information Update: Bayer: Litigation Call Número de registro: 269107 20/08/2018 10:46 BAYER AKTIENGESELLSCHAFT Others on business performance and financial information Bayer: Litigation Call Número de registro: 269084 17/08/2018 15:35 BAYER AKTIENGESELLSCHAFT Legal disputes Bayer rejects WirtschaftsWoche report on Dicamba lawsuits Número de registro: 269080 16/08/2018 14:38 BAYER AKTIENGESELLSCHAFT Mergers, splits, dissolutions and spin-offs Bayer: Conditions for beginning Monsanto integration fulfilled Número de registro: 269067 08/08/2018 15:43 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Supplemental financial information ahead of Q2 2018 results Número de registro: 268980 01/08/2018 13:09 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer receives approval of new treatment regimen for Eylea® in the EU Número de registro: 268744 31/07/2018 15:57 BAYER AKTIENGESELLSCHAFT Mergers, splits, dissolutions and spin-offs LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit Número de registro: 268711 20/06/2018 09:00 BAYER AKTIENGESELLSCHAFT Fixed income issues Bayer concludes refinancing of the Monsanto acquisition by placing bonds with a volume of 5 billion euros Número de registro: 266988 Página 10 de 137 «...678910...»
